Invasion of, development within, and exit from hepatocytes by Plasmodium is essential for the 24 parasite to establish the malaria-causing erythrocytic cycle. Identification of signaling pathways 25 that operate during the pre-erythrocytic cycle provides insights into a critical stage of infection and 26 potential targets for chemoprevention of disease. Calcium Dependent Protein Kinases (CDPK) 27
represent a kinase family that is present in Plasmodium but absent in mammals. We demonstrate 28 that P. berghei homologs of CDPK1, CDPK4 and CDPK5 play overlapping but distinct roles in 29 sporozoite invasion and parasite egress from hepatocytes. All three kinases are expressed in 30 sporozoites. All three are required for optimal motility of sporozoites and consequently their 31 invasion of hepatocytes. Increased cGMP compensates for the functional loss of CDPK1 and 32 CDPK5 during sporozoite invasion but cannot overcome CDPK4's loss. CDPK1 and CDPK5 33 expression is downregulated after sporozoite invasion. CDPK5 reappears in a subset of late stage 34 liver stages and is present in all merosomes. Chemical inhibition of CDPK4 and depletion of 35 CDPK5 in liver stages suggests that these kinases play a role in the formation and/or release of 36 merosomes from mature liver stages. Furthermore, depletion of CDPK5 in merosomes 37 significantly delays a merosome-initiated erythrocytic cycle without affecting the infectivity of 38 hepatic merozoites. These data suggest that CDPK5 is required for the release of hepatic 39 merozoites from merosomes. Our work provides the first evidence that sporozoite invasion 40 requires CDPK1 and CDPK5 and that the release of hepatic merozoites is a regulated process. 41 42 CDPK4 and CDPK6 function in invasion by P. berghei sporozoites since their loss reduces the 89 percentage of sporozoites that enter hepatocytes (12, 19) while deletion of CDPK1 in sporozoites 90 did not reveal a significant defect in parasite invasion of or egress from hepatocytes (8). These 91 results suggested that other CDPKs could play a compensatory and complementary role during 92 sporozoite invasion and parasite exit from hepatocytes. 93 94
Here we examine the role of CDPK1, CDPK4 and CDPK5 in sporozoite motility, traversal 95 through, invasion of and egress from infected hepatocytes, using conditional protein depletion in 96 the rodent model, P. berghei. P. berghei offers the distinct advantage of an experimentally 97 accessible pre-erythrocytic cycle. We demonstrate that in P. berghei sporozoites, CDPK1 98 (PBANKA_0314200), CDPK4 (PBANKA_0615200) and CDPK5 (PBANKA_1351500) are 99
individually required for motility. The loss of each kinase decreases sporozoite motility and 100 consequently significantly reduces their invasion of hepatocytes. CDPK5 is required for parasite 101 egress from hepatocytes and for release of hepatic merozoites from merosomes. Our study is the 102 first demonstration of CDPK1's and CDPK5's role in sporozoite invasion. Furthermore, it 103
provides evidence that release of hepatic merozoites from merosomes is a regulated process that 104 requires CDPK5. 105 106
Results 107 108 CDPK1, CDPK4 and CDPK5 have dynamic expression patterns during the pre-erythrocytic 109 cycle. Since CDPK1, 4, 5 have essential roles in the asexual and sexual cycles, genetic analyses of 110 their functions in pre-erythrocytic stages requires conditional mutagenesis. We adapted a method 111 for conditional protein degradation previously described in P. berghei asexual stages and 112 ookinetes. Here, a target protein is tagged with an Auxin-induced degron (AID) in Ostir1-113 expressing transgenic P. berghei (20) . The tag targets the protein for rapid proteasomal degradation 114 upon the addition of the plant hormone, auxin (Indole-3-acetic acid (IAA). We constructed parasite 115 lines, CDPK4-aid-HA and CDPK5-aid-HA, in which either CDPK4 or CDPK5 were fused with 116 an AID domain and tagged with an HA 2x epitope ( Supplementary Fig. 1A, B ). These two parasite 117 lines and a previously reported CDPK1-aid-HA line (20) were transmitted to mosquitoes for 118 recovery of sporozoites from salivary glands. 119 120
Microscopic examination of midguts revealed fewer oocysts in mosquitoes infected with CDPK1-121 aid-HA or CDPK4-aid-HA parasites compared to mosquitoes infected with an isogenic control 122 (data not shown). Oocyst numbers in mosquitoes infected with CDPK5-aid-HA were equivalent 123 to control (data not shown). Since genomic deletions of CDPK1 and CDPK4 abolish male 124 gametogenesis (15, 16), decreased numbers of oocysts in CDPK1-aid-HA and CDPK4-aid-HA 125 lines suggest that the AID-HA 2x domain either interferes with the activities, expression or 126 localization of CDPK1 and CDPK4 and therefore, partially impairs gametogenesis in these lines. 127
Consistent with reduced midgut infection in CDPK1-aid-HA and CDPK4-aid-HA and normal 128 midgut infection in CDPK5-aid-HA, there was a significant decrease in the average number of 129 salivary gland sporozoites in CDPK1-aid-HA or CDPK4-aid-HA lines but the decrease in ones 130 infected with CDPK5-aid-HA was not significant ( Supplementary Fig. 1C ). Despite reduced 131 numbers of CDPK1-aid-HA and CDPK5-aid-HA sporozoites, we obtained sufficient parasites to 132 conduct our analyses. Due to the low numbers of CDPK4-aid-HA sporozoites, their analysis was 133 more limited. 134 135 We began functional interrogation of CDPKs in the pre-erythrocytic cycle by examining their 136 temporal and spatial protein expression in sporozoites and liver stages. We previously reported the 137 presence of CDPK4 in sporozoites and intracellular liver stage parasites formed 24-65 h post 138 infection (p.i.) of HepG2 cells (19). Here we demonstrate that CDPK1 and CDPK5 are also present 139 in sporozoites ( Fig. 1) and are distributed throughout the cytoplasm. In liver stages, expression of 140 the three kinases is dynamic. CDPK1 and CDPK5 were not detected in early liver stages 24-48 h 141 p.i ( Fig. 1) . At 65 h p.i., when liver stages are close to exiting the hepatocyte, CDPK5 was detected 142 in a subset of liver stages where it sometimes partially co-localized with P. berghei PKG (PbPKG) 143
at the periphery of the infected cell ( Fig. 1B ). CDPK5 expression correlated with developmental 144 maturity since, in the same culture, liver stages that express it were significantly larger in size 145 compared to those that did not have detectable CDPK5 (Fig. 1C ). CDPK5's appearance in mature 146 liver stages suggested its expression may coincide temporally with parasite egress from the 147 infected hepatocyte. Therefore, we examined its expression in merosomes and detached cells 148 released at 65-67h p.i. CDPK5 was detectable in all merosomes/ detached cells and localized to 149 the merosomes periphery, most likely at the membrane (Fig. 2 ). PbPKG was also present in at the 150 merosome periphery but the two kinases did not display significant co-localization. 151 152
We have previously shown that PbPKG is required for merosomes formation or release (19, 21). 153
To obtain a better understanding of the subcellular localization of PbPKG in developing liver 154 stages, we colocalized it with Exp1, a resident protein of the parasitophorous vacuole membrane, 155
HSP70, a cytoplasmic protein and MSP1, a resident protein of the parasite plasma membrane ( Fig.  156 3). PbPKG colocalized with Exp1 but not HSP70 or MSP1. Taken together, these data suggest that 157 in developing liver stages, PbPKG associates with the vacuole membrane. After membrane 158 breakdown in mature liver stages, PbPKG becomes associated with the hepatocyte membrane and 159 is in close proximity to CDPK5. During merosomes formation, the two proteins are associated 160
with the hepatocyte membrane that envelops hepatic merozoites as they are released from the 161 infected cell in the form of merosomes. 162 163
Validation of AID-mediated conditional protein degradation in pre-erythrocytic stages. The 164 unique expression profiles of CDPK1, 4 and 5 in pre-erythrocytic stages suggested some 165 overlapping but also distinct roles. We tested the function of the three kinases in the pre-166 erythrocytic cycle using conditional protein depletion. We tested the efficiency of IAA-mediated 167 protein degradation in CDPK1-aid and CDPK5-aid sporozoites. In both cases, Western blot 168 analysis of protein lysates demonstrated an almost complete loss of AID-tagged proteins ( Fig. 4A ). 169
Since CDPK5-aid-HA protein migrated faster than its predicted molecular weight, we confirmed 170 its loss in IAA-treated sporozoites using immunofluorescence assays ( Supplementary Fig. 1D ). In 171 addition, we confirmed its loss in released merosomes treated with IAA ( Fig. 4B ). 172
Next, we examined if conditions required for protein degradation of AID-tagged proteins 173
have non-specific effects on parasites. We tested IAA's effect on motility, invasion, infectivity 174 and egress of isogenic control sporozoites that lack AID-tagged proteins, Ostir1 (20) . Motility was 175 quantified by live imaging sporozoites after treating with IAA or vehicle (Movie 1-2). The 176
percentage of Ostir1 sporozoites that moved in complete circles was similar in both conditions -177 36% of vehicle-treated (n = 175) and 33% of IAA-treated (n =165). Sporozoite invasion was 178 determined by quantifying the percentage of IAA-and vehicle-treated sporozoites that enter 179
HepG2 cells within 90 min. Their intracellular development was assessed by quantifying the 180 number of liver stages present in HepG2 cells after addition of IAA or vehicle to sporozoite-181 infected HepG2 cultures 2-14 p.i. (Fig. 4C ). There was no significant effect of IAA treatment on 182 sporozoite invasion or on liver stage development as the fraction of sporozoites that entered cells 183 and the number of liver stages was similar in sporozoites treated with IAA or vehicle ( Fig. 4C ). 184
Effect of IAA on parasite egress from hepatocytes was examined by quantifying the number of 185 merosomes present in media of control-infected HepG2 cells treated with IAA 48-65 h p.i. IAA 186 treatment did not significantly affect merosome release, demonstrating that it does not affect egress 187 of control parasites. We conclude that IAA treatment specifically targets aid-HA proteins and does 188 not have a deleterious effect on sporozoites. Therefore, IAA-mediated conditional degradation of 189 proteins is a powerful tool for studying protein function in Fig. 5A ). Instead, they stayed attached to the substrate with either one pole ('waving') or both 202 poles attached (22). These results suggest that the formation and efficient turnover of attachment 203 sites between the sporozoite and the substrate, and consequently sporozoite motility, requires a 204 threshold of Ca 2+ signaling that is reached through the combinatorial function of each of these 205 kinases. Each kinase can partially but not completely compensate for the loss of another. 206
In vivo, motility enables sporozoites to disseminate from the site of bite in the skin by 207 traversing through cell layers, entering a blood vessel and invading a hepatocyte in the liver. 208
Therefore, we examined if decreased motility that results from CDPK1, 4 or 5 depletion has any 209 functional effect on cell traversal by sporozoites and their eventual invasion of hepatocytes. 210
Depletion of CDPK1 or CDPK5 did not decrease cell traversal by sporozoites ( Supplementary Fig.  211 1E). We were unable to test cell traversal in CDPK4-aid-HA sporozoites due to insufficient 212 sporozoites. Invasion of HepG2 cells decreased by approximately 50% in all IAA-treated 213 sporozoites ( Fig. 5B ). These data demonstrate that CDPK1, CDPK4 and CDPK5 are required for 214 sporozoite invasion of hepatocytes and they have partially overlapping functions in the process. 215
Optimal invasion by sporozoites requires all three kinases. The ability of sporozoites to invade 216 cells despite depletion for CDPK1 or CDPK4 or CDPK5 and an apparent complete loss of circular 217 motion in vitro likely suggests that motility on glass coverslips is likely an incomplete 218 representation of sporozoite motility on extracellular matrix. The extracellular matrix might 219 provide a greater number or variety of adhesins using which sporozoites can achieve sufficient 220 motility. 221
Decreased invasion by CDPK1-depleted sporozoites is expected to diminish the number of 222 liver stages formed by these sporozoites. However, previous studies did not find a significant 223 difference in the number of liver stages formed by sporozoites in which the CDPK1 gene was 224 deleted using stage-specific DNA excision (CDPK1 cKO) (8). To reconcile these seemingly 225 contradictory results, we examined the possibility that CDPK1 protein is not significantly reduced 226 in CDPK1 cKO sporozoites, using immunofluorescence assays ( Supplementary Fig. 2 ). Protein 227 was clearly detected in these sporozoites and its presence was entirely consistent with the normal 228 infectivity of CDPK1 cKO sporozoites. In contrast, IAA-mediated CDPK1-aid-HA protein 229 degradation is more efficient (Fig. 4A ). Therefore, conditional degradation of CDPK1 uncovered 230 its function in sporozoite motility and by extension, in host cell invasion for which motility is a 231 pre-requisite. 232
To determine the effect of simultaneous loss of CDPK1 and CDPK4, we generated a 233 parasite line in which both kinases are tagged with AID-HA (CDPK1-aid-HA/CDPK4-aid-HA) 234
(data not shown). CDPK1-AID-HA/CDPK4-AID-HA parasites were viable in the erythrocytic 235 cycle and were transmitted to mosquitoes through a blood meal but they failed to form any salivary 236 gland sporozoites (data not shown). This negative interaction between modified alleles of CDPK1 237 and CDPK4 confirms previous reports of epistatic interactions between the kinases during 238 gametogenesis (6). 239
As an alternative, we utilized a CDPK4-specific bumped kinase inhibitor compound 1294 240 (19, 25) to test the effect of simultaneously inhibiting CDPK4, and CDPK1 or CDPK5. Addition 241 of 1294 (2 µM) to IAA-treated CDPK1-aid-HA and CDPK5-aid-HA sporozoites at the time of 242 invasion significantly decreased the number of intracellular liver stages present at 48 h p.i., 243 compared to liver stages formed by sporozoites treated with IAA or 1294 alone ( Fig. 5C-D) . We 244 tested the possibility that 1294's effect was partly through off-target inhibition of PbPKG, which 245 has a small amino acid at the gatekeeper position. P. berghei sporozoites expressing PbPKG with 246 a gatekeeper substitution (T 619 Q) remain sensitive to 1294 demonstrating that PbPKG is not a 247 major target of the compound ( Supplementary Fig. 3A ). Together, these data suggest that CDPK1, 248
CDPK4 and CDPK5 act together to provide optimal sporozoite invasion. 249
Since CDPKs act downstream of PbPKG during merozoite invasion of erythrocytes 250 (CDPK4 and CDPK1 (6, 7) and egress (CDPK5 (4)), we tested if increasing cGMP levels, and 251
consequently PbPKG signaling, during sporozoite invasion could overcome the loss of CDPK1, 252 CDPK4 or CDPK5. Zaprinast, a phosphodiesterase inhibitor, reversed the effect of depleting either 253 CDPK1 or CDPK5 individually ( Fig. 5C-D) . The number of liver stages formed by CDPK1-254 depleted or CDPK5-depleted sporozoites in the presence of zaprinast was indistinguishable from 255 vehicle-treated sporozoites. However, zaprinast could not overcome simultaneous inhibition of 256 CDPK4 and either CDPK1 or CDPK5 sporozoites ( Fig 6C-D) . These results suggest that PbPKG 257 acts upstream of both CDPK1 and CDPK5 during sporozoite motility and that CDPK4 functions 258 in a pathway that is at least in part independent of PbPKG. 259 260 CDPK5 is required for parasite egress from hepatocytes and from merosomes. Plasmodium's 261 entry into the blood stream after exiting the liver is a two-step process. First, merosomes are 262 extruded from the infected hepatocyte into the blood stream (26, 27). Second, merosomes are 263 carried intact into the lung microvasculature where they disintegrate and release free hepatic 264 merozoites that initiate the first round of erythrocytic infection (27). Egress from hepatocytes 265 requires the activity of parasite PKG (27) and SUB1 (28) but there is little information on processes 266 required for the release of hepatic merozoites from merosomes. 267
The presence of CDPK4 and CDPK5 in late liver stages suggests a possible function during 268 parasite egress from hepatocytes. However, a conditional deletion of CDPK4 gene in sporozoites 269 did not demonstrate a clear effect on the number of merosomes released in culture (19). We 270 attempted to confirm these results using IAA-mediated depletion of CDPK4-aid protein in liver 271 stages but the small number of CDPK4-aid-HA sporozoites made these assays unfeasible. As an 272 alternative, we tested the effect of chemical inhibition of CDPK4 on merosome formation. 273
Addition of 1294 to sporozoite-infected HepG2 cells at 48 -66 h p.i. decreased merosomes 274
released into media at 66 h p.i ( Supplementary Fig. 3B ). The different effects of genetic and 275 chemical inhibition of CDPK4 suggest that parasites can adapt to genetic ablation of CDPK4 in 276 sporozoites but cannot do so in response to chemical inhibition. Since chemical inhibition of kinase 277 activity is rapid, it may not allow sufficient time for upregulation of compensatory pathways that 278
can be upregulated in mutant parasites during their development from sporozoites into merosomes. 279
Depletion of CDPK5-aid in liver stages, starting 48 h p.i., also reduced the number of 280 merosomes formed at 65h p.i. Similar treatment of CDPK1-aid-HA-infected HepG2 cells had no 281 significant effect consistent with the lack of CDPK1 expression in liver stages (Fig. 5E ). These 282 results demonstrate that Ca 2+ signaling through CDPK5 is required for parasite exit from 283
hepatocytes. Since CDPK5 is detected in free merosomes (Fig. 2) , we investigated its function in 284 the release of hepatic merozoites. CDPK5-aid-HA merosomes treated with either IAA or vehicle 285 prior to being injected intravenously into mice. In order to detect infection by hepatic merozoites, 286 blood parasitemia was monitored at 24 h p.i. This time-period enables the initiation and completion 287 of a single asexual cycle in P. berghei. None of the mice infected with CDPK5-depleted 288 merosomes (n = 20) demonstrated parasitemia at 24 h p.i. while all mice infected with vehicle-289 treated merosomes were positive ( Figure 5F ). Mice infected with CDPK5-depleted merosomes 290 became patent on day 3 p.i. (n = 20) and the growth rate of asexual parasites was similar in the 291 two groups ( Supplementary Fig 3C) . We conclude that CDPK5's loss in merosomes does not affect 292 replication of asexual stages. 293
The longer pre-patent period and the lower parasitemia at 24h p.i. from CDPK5-depleted 294 merosomes suggested that CDPK5 plays an important role in the release of hepatic merozoites 295 from merosomes and/or in their invasion of erythrocytes. To distinguish between these two 296 possibilities, we tested the effect of CDPK5 depletion of the infectivity of hepatic merozoites. We 297 manually ruptured vehicle-or IAA-treated CDPK5-aid-HA merosomes prior to their injection into 298 mice. In this case, all mice were patent at 24 p.i. and the difference in average parasitemias of the 299 two groups of mice was much smaller ( Figure 5F ). Together, these results are consistent with a 300 model in which CDPK5 functions in the rupture of merosome membrane and release of hepatic 301 merozoites. 302 303
Discussion 304
Initiation of the erythrocytic cycle by hepatic merozoites is possibly the least-understood 305 step of the malaria infection cycle. Hepatic merozoites have a single opportunity to infect host 306 cells and their release at the wrong time or place, for example in a non-vascular environment, 307 would prevent or severely debilitate the launch of the erythrocytic cycle. While there is significant 308 understanding at the molecular level of events leading to the release of merozoites from infected 309 erythrocytes, almost nothing is known of how hepatic merozoites are released from merosomes. 310 We provide strong evidence that release of hepatic merozoites from merosomes is a parasite-311 regulated process. The breakdown of the merosome membrane is likely a response to 312 environmental cues that result in Ca 2+ flux in merosomes, activation of CDPK5 and release of 313 proteolytic enzymes. 314
Depletion of CDPK5 from merosomes does not impair the ability of hepatic merozoites to 315 invade erythrocytes since manually-released hepatic merozoites from CDPK5-depleted 316 merosomes initiate erythrocytic infection normally. In contrast, intact merosomes depleted for 317 CDPK5 exhibit a significant delay in initiating erythrocytic infection as demonstrated by the 318 significantly lower blood stage parasitemia in mice 24 h p.i.. It has been suggested that a lung-319 receptor mediated mechanism arrests merosomes in lungs where infection of erythrocytes by 320 hepatic merozoites is facilitated by the low macrophage density and reduced shear forces in the 321 pulmonary capillary bed from lower blood velocity (27). We hypothesize that interaction between 322 merosomes and a tissue-specific receptor could trigger CDPK5-mediated release of hepatic 323 merozoites. Another mechanism that could account for delayed patency of CDPK5-depleted 324 merosomes is better clearance by the host immune system. Testing these models requires 325 development of quantitative assays for release of hepatic merozoites from merosomes. In addition, 326
it will be interesting to explore if CDPK5's function during hepatic merozoite release requires 327 CDPK5 to localize to the merosome membrane. 328
CDPK5 is also required for the formation of merosomes. The relatively modest effect on 329 merosomes formation could suggest that CDPK5 primarily functions after merosomes have been 330 released from the hepatocyte i.e. in the release of hepatic merozoites. Alternatively, CDPK4, which 331 is also present in liver stages at 65 h p.i., could have a redundant role with CDPK5 in merosome 332 formation. It is also possible that CDPK5 function in merosome formation is compensated by 333
PbPKG. We cannot rule out the possibility that IAA-mediated depletion of CDPK5-aid-HA in 334 intracellular and intravacuolar parasite stages, such as liver stages, is less efficient compared to its 335 depletion in sporozoites or released merosomes. Incomplete depletion of CDPK5 in liver stages 336 could provide sufficient protein for close-to-normal function in merosome formation. 337
The relative dearth of knowledge about the function of CDPKs in pre-erythrocytic stages 338
can be attributed, in part, to the difficulties faced in functional analyses in pre-erythrocytic stages 339 of kinases that have indispensable functions in the asexual and sexual cycles. Despite these 340 challenges, it is important to understand functions of CDPKs in these stages because they 341 constitute the first step of the mammalian infection, and the study of CDPKs' in these stages could 342
identify targets for malaria chemoprevention. In addition, it will provide a fuller view of the stage-343 specific and stage-transcending functions of different family members. The relative contribution 344 of different family members in different parasite stages may be determined by the threshold of 345 Ca 2+ signaling required for different cellular processes, the sensitivity of specific kinases to Ca 2+ 346 level, their expression level and subcellular localization. 347
Our work reveals nuances of CDPK signaling in different parasite stages. in sporozoite motility and that these functions are only partially overlapping. Depletion of any of 361 these kinases significantly reduces sporozoite motility. Since IAA-treated sporozoites attach to 362 the surface, we speculate that their defective motility is likely due to dysregulation in turnover of 363 adhesion sites that is required for the sporozoites to move forward (24). In contrast, in ookinetes, 364 individual depletion or inhibition of CDPK1 and CDPK4 does not affect motility in vitro and only 365 simultaneous loss significantly reduces ookinete speed (6). The implication is that each kinase can 366 fully compensate for the other during ookinete traversal (6). As shown previously, ookinete 367 motility and traversal through the midgut epithelium relies more heavily on CDPK3 (11). 368 We were surprised to find that, despite the loss of continuous movement, sporozoites 369 depleted of CDPK1 or CDPK5 maintained the ability to traverse through cells albeit being 370 significantly attenuated in invasion. Sporozoites traverse through cells by forming a transient 371 vacuole without the formation of a tight junction between the sporozoite and hepatocyte 372 membranes (29). Productive invasion requires the formation of a tight junction and sporozoites are 373 contained within a parasitophorous vacuole. Since loss of CDPK1 and CDPK5 reduces only 374 invasion, it implies that residual motility in depleted sporozoites is sufficient for traversal. We 375
suggest that CDPK1 and CDPK5 could regulate the formation of the tight junction or another 376 process specific to the form of cell entry that is accompanied by the formation of a permanent 377 vacuole. 378
Optimal invasion by sporozoites requires a network of CDPKs -CDPK1, CDPK4 and 379 CDPK5, as shown here, and CDPK6 as shown previously (12). We posit that, in vivo, reduced 380 motility that results from inhibition or loss of CDPK1, CDPK4 or CDPK5 will severely impair 381 cell entry by sporozoites, thereby attenuating hepatocyte infection. In contrast, during invasion by 382 asexual stages, the loss of CDPK1 or CDPK4, individually or together, has no significant effect. 383
The role of CDPK4 in erythrocytic invasion is seen only in the background of reduced PKG 384 activity (6). CDPK1's role in invasion is uncovered only in the background of simultaneous 385 reduction in PKG and CDPK4 activities. It is possible that erythrocytic stages adapt to the loss of 386 CDPK1 and CDPK4 by upregulating another CDPK member or PKG activity. 387 We have also determined that CDPK4 and CDPK5 play a role in merosome formation ( Fig.  388 5E and Supplementary Fig. 3B ). Although conditional deletion of the CDPK4 gene in sporozoites 389 (CDPK4 cKO) did not result in a significant decrease in merosome formation (19), its chemical 390 inhibition did. We consider it unlikely that 1294-mediated reduction in merosomes is due to off-391 target effects on PbPKG because 1294's IC 50 against PfPKG is a fold higher than its IC 50 for 392 PfCDPK4 and P. berghei sporozoites carrying a gatekeeper mutation in PbPKG remain sensitive 393 to 1294 ( Supplementary Fig 3A) . The lack of merosome reduction in CDPK4 cKO parasites may 394 be attributed to upregulation of compensatory pathways. To test these models, we wanted to 395 determine the effect on merosome formation of rapid reduction in CDPK4 protein. We were unable 396 to do so because CDPK4-aid-HA sporozoites are not produced in sufficient numbers for robust 397 merosome assays. Further studies using alternative methods for depleting CDPK4 exclusively in 398 liver stages and compounds with greater specificity for CDPK4 will address this issue. 399 400
Materials and Methods 401
Ethics statement. All animal work in this project was reviewed and approved by the Institutional 402
Animal Care and Use Committee (IACUC) of Rutgers New Jersey Medical School, approval 403 number TR201900067, following guidelines of the Animal Welfare Act, The Institute of 404
Laboratory Animal Resources Guide for the Care and Use of Laboratory Animals, and Public 405
Health Service Policy. 406 407
Construction of AID-HA tagged parasite lines. The targeting plasmid for modifying CDPK4 with 408 the aid-HA degron was constructed by amplifying a C-terminus fragment of CDPK4 using PCR 409 primers AATTGGAGCTCCACCGCGGCAAGTATTAAGTGGTATTACATATATG and 410 TCATTCTAGTCTCGAGATAGTTACATAGTTTTATTAACATGTCTC. The PCR product 411 was cloned into the previously described AID-tagging plasmid expressing mCherry (pG364) (20) , 412
using SacII and XhoI. The targeting plasmid for modifying CDPK5 with the aid-HA degron was 413 constructed by cloning a fragment amplified using PCR primers AATTGGAGCT-414  CCACCGCGGCATAGAGATTTAAAGCCAGAA and TCATTCTAGTCTCGAGAGATTGT-415 CTTCCAGACATC, into a previously described AID-tagging plasmid expressing GFP (pG362) 416 (20) . The CDPK4-aid-HA targeting plasmid was linearized using BspEI and the CDPK5-aid-HA 417 targeting plasmid was linearized using BclI. Linearized plasmids were transfected into the 418 previously described OsTIR1-expressing parent line (20) , using standard procedures (30). 419
Transfected parasites were selected by pyrimethamine treatment and clonal lines were established 420 through limited dilution. Modification of CDPK4 was confirmed using PCR primer pairs P1 421 (TGAAGTAGATGCAGCTAG) + P2 (GTTAAATGTGGGGTAAAAAA) and P3 422 (GTATTTACCCTGTCATACAT) + P4 (GATTAAGTTGGGTAACGC). Modification of 423 CDPK5 was confirmed using PCR primer pairs P2 + P5 (CAAATGGATCATCCAAATATT) and 424 (P3) + P6 (AAGGAATAGAAGGTAGAAATTG). 425
Mosquito infections. Anopheles stephensi mosquitoes were fed on infected Swiss-Webster mice. 426
Mosquitoes were maintained on 20% sucrose at 25°C at a relative humidity of 75-80%. 427
Sporozoites were obtained by crushing salivary glands dissected on days 18-25 post-feeding. 428
Sporozoites were counted in a hemocytometer. 429
Immunofluorescence assays for protein detection in sporozoites, liver stages and merosomes. 430
Primary antibodies used were: anti-HA (Biolegend, 1:200 -1:400), anti-PKG (1:1000 (19)), anti-431 CS (3D11, 1 µg/mL), anti-HSP70 (2E4, 1.0 µg/mL (31)), anti-Exp1 (1:1000, kind gift of Dr. 432
Volker Heussler) and anti-MSP1 (1:400, kind gift of Dr. Anthony Holder). Secondary antibodies 433
(anti-mouse Alexa488, anti-rabbit Alexa594 and anti-chicken Alexa 594, Molecular Probes) were 434 used at a dilution of 1:3000. 435 436
Sporozoites (0.5-1 x 10 6 ) were purified as previously described(32), air-dried at room temperature 437 on poly L-lysine coated glass slides. LabTek slides. Invasion assays were performed as previously described (33). Briefly, 90 min after 492 sporozoite addition, cells were fixed with 4% PFA, blocked with 3% BSA in PBS and incubated 493 with 3D11 (1µg/ mL) for 1h at RT. After washes with PBS, cells were incubated with anti-mouse 494
Alexa594 (1:3000) for 1h at RT. Cells were permeablized with cold methanol for 15 min, blocked 495 and incubated with 3D11. After washes, cells were incubated with anti-mouse Alexa488 (1:3000) 496
for 1h at RT. The number of sporozoites that became intracellular were determined by calculating 497 the difference in numbers of sporozoites that stain with Alexa488 and Alexa594. The percentage 498 of sporozoites that invaded was calculated by determining the percentage of total sporozoites that 499 were intracellular. 500 501
Sporozoite Infection Assays. Sporozoites, pre-treated with IAA (500 µM), vehicle (1% ethanol), 502 1294 (2 µM) and zaprinast (50 µM), were added to HepG2 cells, for a final volume of 200 µL. 503
Sporozoite-containing medium was replaced with complete DMEM at 2 h p.i. and 24 h p.i. Cells 504
were fixed with 4% PFA at 48 h p.i., permeablized with cold methanol for 15 min, blocked for 1 505 h with 3% BSA in PBS before incubation with the anti-HSP70 and anti-mouse Alexa488 506 antibodies as described above. The number of liver stages was determined through microscopic 507 examination. 508 509
Liver stage development. Sporozoites (2 -4 x10 4 /well), in DMEM supplemented with 10% FCS, 510
were added to HepG2 cells plated in 8-chamber LabTek slides. To determine its effect on liver 511 stage development, IAA or vehicle was added to infected HepG2 cells 3 h p.i.. Medium was 512 replaced at 14 h p.i. and cells fixed for immunofluorescence analysis using anti-HSP70 as 513 described above. 514 515
Merosome formation. Sporozoites (8 -10 x10 4 /well) were added to sub-confluent HepG2 cells 516 plated on glass coverslips in 24-well plates. Medium was replaced every 12 h. To determine its 517 effect on the development and release of merosomes, IAA was added to infected HepG2 cells 48 518 h p.i.. The number of merosomes present in the medium was quantified in a hemocytometer at 65 519 -67 h p.i.. 520 521
In vivo infections. Merosomes were treated with IAA (500 µM) or vehicle (1% ethanol) for 90 min 522 at RT in DMEM. Following treatment, they were injected intravenously into Swiss-Webster 523 female mice (4-5 mice/group, 6-8 weeks) either immediately (200 intact merosomes/mouse) or 524 after passaging 10 times through a 23G needle (5000 ruptured merosomes/mouse) as previously 525 described (34). Blood was collected from mice 24 h p.i. and analyzed by flow cytometry for the 526 number of GFP-positive events as previously described (35). A total of 1x10 5 events was counted 527 per sample. Parasitemia was confirmed through daily microscopic examination of Giemsa-stained 528 blood smears. 529
Statistical analysis. Data were examined using GraphPad Prism v7. 530
